|
J Biol Chem, Vol. 275, Issue 15, 10845-10850, April 14, 2000
Ca2+-activated but Not G Protein-mediated Inositol
Phosphate Responses in Rat Neonatal Cardiomyocytes Involve Inositol
1,4,5-Trisphosphate Generation*
Scot J.
Matkovich and
Elizabeth A.
Woodcock
From the Cellular Biochemistry Laboratory, Baker Medical Research
Institute, Melbourne 8008, Victoria, Australia
 |
ABSTRACT |
Inositol phosphate (InsP) responses to receptor
activation are assumed to involve phospholipase C cleavage of
phosphatidylinositol 4,5-bisphosphate to generate
Ins(1,4,5)P3. However, in
[3H]inositol-labeled rat neonatal cardiomyocytes (NCM)
both initial and sustained [3H]InsP responses to
1-adrenergic receptor stimulation with norepinephrine (100 µM) were insensitive to the phosphatidylinositol
4,5-bisphosphate-binding agent neomycin (5 mM).
Introduction of 300 µM unlabeled Ins(1,4,5)P3 into guanosine 5'-3-O-(thio)triphosphate
(GTP S)-stimulated, permeabilized [3H]inositol-labeled
NCM increased [3H]Ins(1,4,5)P3 slightly but
did not significantly reduce levels of its metabolites
[3H]Ins(1,4)P2 and [3H]Ins(4)P,
suggesting that these [3H]InsPs are not formed
principally from [3H]Ins(1,4,5)P3. In
contrast, the calcium ionophore A23187 (10 µM) provoked
[3H]InsP responses in intact NCM which were sensitive to
neomycin, and elevation of free calcium in permeabilized NCM led to
[3H]InsP responses characterized by marked increases in
[3H]Ins(1,4,5)P3 (2.9 ± 0.2% of total
[3H]InsPs after 20 min of high Ca2+ treatment
in comparison to 0.21 ± 0.05% of total
[3H]InsPs accumulated after 20 min of GTP S
stimulation). These data provide evidence that Ins(1,4,5)P3
generation is not a major contributor to G protein-coupled InsP
responses in NCM, but that substantial Ins(1,4,5)P3
generation occurs under conditions of Ca2+ overload. Thus
in NCM, Ca2+-induced Ins(1,4,5)P3 generation
has the potential to worsen Ca2+ overload and thereby
aggravate Ca2+-induced electrophysiological perturbations.
 |
INTRODUCTION |
Generation of inositol 1,4,5-trisphosphate
(Ins(1,4,5)P3),1
a Ca2+-mobilizing second messenger, is critical in
mediating responses to hormone stimulation in a wide variety of cell
types (1). Activation of phospholipase C (PLC) generates both
Ins(1,4,5)P3 and sn-1,2-diacylglycerol from the
precursor phospholipid PtdIns(4,5)P2. However, all known
PLC isozymes have the capacity to hydrolyze PtdIns and PtdIns(4)P as
well as PtdIns(4,5)P2, although with lower potency (2, 3).
While there is some difference in substrate selectivity between the
three PLC classes ( , , and ), activity toward
PtdIns(4,5)P2 is somewhat higher than toward PtdIns(4)P
when measurements are made using PLCs reconstituted in lipid vesicles
(2, 3). Nonetheless, this suggests the possibility that cleavage of
PtdIns(4)P in addition to PtdIns(4,5)P2 could be a
substantial contributor to the overall InsP response. Early studies of
InsP responses led to the suggestion that generation of
Ins(1,4,5)P3 takes place during the initial stage of
agonist stimulation, while the sustained InsP response depends on
cleavage of PtdIns to Ins(1)P (4-6). However, the lack of potent,
readily available inhibitors of Ins(1,4,5)P3 metabolism has
meant that such ideas have never been substantiated, and
Ins(1,4,5)P3 has generally been assumed to be the primary
source of all InsPs that accumulate in response to receptor
stimulation, including InsPs generated in the myocardium.
Beat-to-beat regulation of cardiac muscle Ca2+ is primarily
controlled by ryanodine receptors on the sarcoplasmic reticulum. Ins(1,4,5)P3-mediated Ca2+ responses in cardiac
myocytes are relatively slow and weak and have been characterized as
Ca2+ oscillations (7, 8) which have potential proarrhythmic activity. Intracellular application of Ins(1,4,5)P3 causes
action potential prolongation and degeneration (9) including activation of proarrhythmic sodium-calcium exchange (10). Furthermore, arrhythmias
occurring during ischemia and reperfusion correlate with cardiac
Ins(1,4,5)P3 content (11-17). In the face of evidence for
a pathological role of Ins(1,4,5)P3 in the myocardium
(reviewed in Ref. 18), it is important to better understand the
mechanisms responsible for its generation in cardiac myocytes and also
the mechanisms suppressing its generation under physiological circumstances.
Rat neonatal cardiomyocytes (NCM) represent a convenient system for the
modelling of myocardial signaling. InsP responses to norepinephrine
(NE) in myocytes are mediated via 1-adrenergic receptors, coupling via Gq to PLC- isoforms (19, 20) of
which PLC- 1 and PLC- 3 are expressed in heart (21-23). Our
initial studies indicated that NE stimulation in NCM was largely
insensitive to the PtdIns(4,5)P2-binding agent neomycin
(24), unlike findings in other cell types, implying that responses are
largely independent of Ins(1,4,5)P3. This prompted us to
examine the source of InsPs in NCM generated in response to
1-adrenergic activation. In this study, we present the
first direct evidence that G protein activation of NCM stimulates an
InsP response that is largely independent of Ins(1,4,5)P3
generation. In contrast, the InsP response to elevation of
intracellular Ca2+ is primarily via
Ins(1,4,5)P3.
 |
EXPERIMENTAL PROCEDURES |
Culture of Neonatal Cardiomyocytes--
NCM were prepared from
1- to 3-day-old Sprague-Dawley rat pups, essentially as described
previously (25). NCM were isolated by repeated trypsin digestion
with gentle mechanical dispersion, pre-plated twice for 30 min
each to remove nonmyocytes and left to attach for 18 h in medium
199, 10% fetal calf serum, 0.1 mM bromodeoxyuridine, 50 units/ml penicillin G, and 50 µg/ml streptomycin sulfate onto
uncoated dishes, at a typical seeding density of 700 cells/mm2. Medium was then replaced with a defined
serum-free medium consisting of medium 199, 2% (w/v) bovine serum
albumin, 10 µg/ml human insulin, 10 µg/ml bovine apo-transferrin,
0.1 mM bromodeoxyuridine, 50 units/ml penicillin G, and 50 µg/ml streptomycin sulfate. Bromodeoxyuridine was omitted after 3 days and cells were labeled with [3H]inositol in defined
serum-free medium for 48 h prior to experiments. Wells were washed
extensively with nonradioactive medium before use.
Saponin Permeabilization of NCM--
Cell permeabilization was
achieved by treatment with 50 µg/ml saponin in an intracellular-like
medium containing an ATP-generating system for 4 min at 37 °C.
Intracellular medium had the following constituents (in
mM): KCl, 110; NaCl, 10; KH2PO4, 1;
MgSO4, 5; EGTA, 1; Hepes, 20; ATP, 2; creatine phosphate,
10; with 20 Sigma units/ml creatine phosphokinase, 0.2% (w/v) bovine
serum albumin and CaCl2 to give a free [Ca2+]
of 100 nM (determined by reference to a
Ca2+-EGTA titration curve), adjusted to pH 7.2 with NaOH.
Plates were washed 4 times with intracellular medium and fresh
intracellular medium was added before the commencement of
[3H]InsP generation protocols.
Generation and Extraction of [3H]InsPs--
10
mM LiCl was added 10 min before the addition of an
appropriate stimulator to intact NCM in medium 199, or permeabilized NCM in intracellular medium with an ATP-generating system, and maintained during the treatment period in order to inhibit InsP breakdown by inositol polyphosphate-1-phosphatase and inositol monophosphatase (26, 27). 1 µM Propranolol was also added to intact NCM to block -adrenergic receptors. For stimulation of
intact NCM, stock solutions of 10 mM NE in 0.5 M 2-mercaptoethanol (to inhibit catecholamine oxidation) or
10 mM A23187 in dimethyl sulfoxide were prepared freshly on
the experimental day and diluted into medium 199 containing LiCl and
propranolol just before use. After stimulation, medium was removed from
intact NCM and the reaction terminated by the addition of ice-cold 5%
trichloroacetic acid, 2.5 mM disodium EDTA, 5 mM sodium phytate (sodium inositol hexakisphosphate).
Permeabilized NCM reactions were stopped by the addition of an equal
volume of ice-cold 10% trichloroacetic acid, 5 mM
disodium-EDTA, 5 mM sodium phytate to the intracellular medium. Wells were scraped, washed once with 5% trichloroacetic acid,
2.5 mM disodium EDTA, 5 mM sodium phytate and
the extracts collected. Trichloroacetic acid-insoluble material was
removed by low-speed centrifugation, a 1:1 mixture of
freon/tri-n-octylamine was added to remove trichloroacetic
acid, and the upper aqueous phase containing [3H]InsPs
was prepared for high performance liquid chromatography as described
previously (28).
Analysis of [3H]InsP Isomers--
Separation and
quantitation of [3H]InsP isomers was performed using
established anion-exchange high performance liquid chromatography techniques (28, 29). Briefly, 3H-labeled compounds were
eluted with a complex gradient of ammonium phosphate at pH 3.8. Retention times and integrated peak values were obtained via an on-line
-counter. Identification of [3H]InsP isomers was made
with reference to appropriate commercial standards.
Materials--
Fetal calf serum was specially selected for low
endotoxin and obtained from the Commonwealth Serum Laboratories,
Parkville, Australia. Medium 199, Hepes, L-glutamine,
bovine serum albumin, NaHCO3, and other materials for the
preparation of cell culture solutions and media were cell culture
grade, obtained from Sigma and dissolved in highly purified Milli-Q
H2O. Human insulin was ActrapidTM from Novo
Nordisk Pharmaceuticals, and bovine apo-transferrin was from Sigma.
GTP S and Ins(1,4,5)P3 were obtained through Sigma and
Sapphire Bioscience, Australia.
[3H]Ins(1,4,5)P3 (21.00 Ci/mmol) was
purchased from NEN Life Science Products Inc. and
[3H]inositol (18.00 Ci/mmol) was obtained from Amersham
Pharmacia Biotech. Other reagents were obtained from Sigma or
BDH/AnalaR and were of analytical reagent grade.
Treatment of Data--
Differences between treatment groups were
assessed by unpaired Student's t test or 1-way ANOVA as
appropriate, and accepted as statistically significant at
p < 0.05. Unless otherwise noted, results shown are
from representative experiments, which were independently repeated
three times.
 |
RESULTS |
Time Course of NE and A23187 Stimulation of InsP
Generation--
NCM were used for [3H]InsP generation
experiments at 5 days after initial isolation and radiolabeled with 20 µCi/ml [3H]inositol 48 h before experiments. As it
has been suggested that short- and long-term stimulation of PLC have
different characteristics, we examined changes in individual
[3H]InsP isomers in detail over the first minute of PLC
stimulation and compared this to a 20-min stimulation period. After a
10-min pretreatment period with 10 mM LiCl and 1 µM propranolol in medium 199, PLC was activated by
stimulation of 1-adrenergic receptors with 100 µM NE, or by raising intracellular Ca2+ by
treatment with 10 µM A23187, in the continued presence of LiCl and propranolol, for the specified time periods.
In agreement with previous reports (30, 31) we found a transient
increase in [3H]Ins(1,4,5)P3 followed by a
decrease during the first minute of NE stimulation (Fig.
1). Stimulation by A23187 followed a
similar pattern, although the response was of lower magnitude. From 1 to 20 min, further increases in
[3H]Ins(1,4,5)P3 were only marginal. As
attack by 5-phosphatase and 3-kinase enzymes on
Ins(1,4,5)P3 is not inhibited by Li+, this
observation alone does not reflect the amount of
[3H]Ins(1,4,5)P3 which could have been
generated by PLC activity over this time frame.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 1.
Time course of NE and A23187 responses.
[3H]Inositol-labeled NCM were incubated in medium 199 containing 10 mM LiCl and 1 µM propranolol
for 10 min. 100 µM NE or 10 µM A23187 was
then added for the indicated time period in the continued presence of
LiCl and propranolol. In the absence of agonist,
[3H]InsPs did not rise detectably during the first minute
and at 20 min, unstimulated total [3H]InsPs increased to
4.3 × 104 cpm/well. Circles represent NE
stimulation and triangles represent A23187 stimulation.
Results shown are mean values from a representative experiment of three
performed in duplicate.
|
|
Levels of [3H]Ins(1,4)P2 and its immediate
dephosphorylation product [3H]Ins(4)P followed a similar
rise and fall to [3H]Ins(1,4,5)P3 during the
first minute of stimulation (Fig. 1), but continued to increase
steadily thereafter in the presence of Li+, an
uncompetitive inhibitor of Ins(1,4)P2 and Ins(4)P breakdown (26, 32). As [3H]Ins(1,4)P2 could be produced
either by PLC hydrolysis of [3H]PtdIns(4)P or by
breakdown of [3H]Ins(1,4,5)P3 via a
5-phosphatase, these data demonstrate continued PLC activity over a
20-min period but do not indicate whether the primary product of PLC
hydrolysis of phosphoinositides is Ins(1,4)P2 or
Ins(1,4,5)P3.
Neomycin Sensitivity of NE and A23187 Responses--
30 s of
treatment with either NE or A23187 stimulated overall
[3H]InsP generation (Fig.
2, a and b) and
increased [3H]Ins(1,4,5)P3 (Fig. 1). However,
the inclusion of 5 mM neomycin, an aminoglycoside that
binds to PtdIns(4,5)P2 (24) and inhibits production of
Ins(1,4,5)P3 (33, 34) did not reduce [3H]InsP
accumulation in response to NE either at 30 s (Fig. 2a) or at 20 min (Fig. 2c).

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 2.
Effect of neomycin on stimulated
[3H]InsP responses.
[3H]Inositol-labeled NCM were washed with medium 199 and
incubated with fresh medium containing 10 mM LiCl and 1 µM propranolol for 10 min with or without 5 mM neomycin. 100 µM NE or 10 µM
A23187 was then added for 30 s or 20 min. Open bars
represent timed control, filled bars represent NE
(panels a and c) or A23187 (panels b
and d), and hatched bars represent NE or A23187
with neomycin. Results are presented as mean ± S.E. of a
representative experiment of three performed in triplicate. * signifies
p < 0.05 between treatments with or without
neomycin.
|
|
In contrast, when NCM were stimulated with A23187 for either 30 s
(Fig. 2b) or 20 min (Fig. 2d), 5 mM
neomycin caused ~50% inhibition of the response. Approximately 50%
inhibition by this concentration of neomycin has been reported in a
number of different cell types (33, 34). Addition of neomycin in the
absence of agonist had no effect on unstimulated
[3H]InsPs (data not shown).
Ca2+-stimulated and G Protein-activated
[3H]InsP Responses in Permeabilized
NCM--
[3H]Inositol-labeled NCM were permeabilized,
pretreated for 10 min with 10 mM LiCl, and
[3H]InsP responses were stimulated by adding 10 µM GTP S, or AlF4 (to
activate heterotrimeric G proteins), or by increasing free [Ca2+] from 100 nM to 10 µM, in
the continued presence of Li+. [3H]InsP
generation was measured after 1 or 20 min of stimulation to examine
both the early and sustained phase of [3H]InsP
generation, as in intact NCM experiments.
10 µM GTP S did not cause a detectable increase in
total [3H]InsPs or in
[3H]Ins(1,4,5)P3 at 1 min (data not shown).
To ensure this did not reflect slow guanine nucleotide exchange on
G q (35), the experiments were repeated using
AlF4 which causes an immediate
activation of Gq, independent of GDP/GTP exchange (20, 36).
After 1 min of AlF4 treatment, total
[3H]InsP content was not significantly increased compared
with control (Fig. 3b), and
there was no increase in [3H]Ins(1,4,5)P3
(Fig. 3a). 20 min of G protein stimulation with GTP S led
to an approximate doubling of total [3H]InsPs
(Fig. 3d), again without detectable increase in
[3H]Ins(1,4,5)P3 (Fig.
3c).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 3.
[3H]InsP generation in response
to elevated free Ca2+ and G protein stimulation in
permeabilized NCM. [3H]Inositol-labeled,
permeabilized NCM were pretreated for 10 min with Li+ at a
free [Ca2+] of 100 nM and then exposed to
Li+ for a further 1 or 20 min (open bars),
treated with AlF4 (20 µM
AlCl3, 5 mM sodium fluoride) for 1 min
(panels a and b) or with 10 µM
GTP S for 20 min (panels c and d)
(hatched bars), or treated with 10 µM free
Ca2+ for 1 or 20 min (filled bars). Results are
presented as mean ± S.E. of a representative experiment of three
performed in triplicate. * signifies p < 0.05 versus no additions.
|
|
In contrast to 1 min of G protein activation, when elevated
[Ca2+] was used to activate [3H]InsP
generation for 1 min, total [3H]InsPs were significantly
increased (Fig. 3b). This stimulation was characterized by a
very marked rise in the level of
[3H]Ins(1,4,5)P3 (Fig. 3a).
Although total [3H]InsPs in response to 20 min of 10 µM Ca2+ were only slightly increased above
those seen with 20 min of 100 nM Ca2+ (Fig.
3d), the rise in [3H]Ins(1,4,5)P3
was sustained, with the level of
[3H]Ins(1,4,5)P3 at 20 min of 10 µM Ca2+ remaining significantly higher than
that at 20 min of 100 nM Ca2+ (Fig.
3c). Thus, unlike the sustained effect of GTP S, the
[3H]InsP response to elevated Ca2+ involved
significant increases in
[3H]Ins(1,4,5)P3.
Blockade of [3H]Ins(1,4,5)P3 Breakdown
during G Protein-activated [3H]InsP Generation in
Permeabilized NCM--
The low sensitivity to neomycin in
NE-stimulated NCM (together with demonstrable neomycin inhibition of
A23187 responses) suggested that the major proportion of InsPs detected
upon G protein activation of phospholipase C do not arise from
generation of Ins(1,4,5)P3 and its subsequent breakdown. In
order to investigate this further, and considering that permeabilized
NCM experiments showed similar effects of G protein activation and
Ca2+ elevation to those observed in intact NCM, we
attempted to block metabolism of any
[3H]Ins(1,4,5)P3 generated in permeabilized
NCM to ascertain its contribution to the overall [3H]InsP
response. As the Km of the enzymes responsible for
Ins(1,4,5)P3 metabolism is in the order of 10 µM (27, 37) 300 µM unlabeled
Ins(1,4,5)P3 was added to the medium to competitively inhibit breakdown of [3H]Ins(1,4,5)P3. If
other [3H]InsPs detected in permeabilized NCM arise from
metabolism of [3H]Ins(1,4,5)P3, this maneuver
would be expected to increase the amount of
[3H]Ins(1,4,5)P3 detected at the expense of
labeled metabolites.
Fig. 4 shows the effects of addition of
300 µM Ins(1,4,5)P3 to unstimulated and
GTP S-stimulated permeabilized NCM. When 10 µM GTP S
was added to permeabilized NCM for 20 min, there was a significant
increase in total [3H]InsPs consisting primarily of
[3H]Ins(1,4)P2 and [3H]Ins(4)P
but not [3H]Ins(1,4,5)P3. In the presence of
300 µM Ins(1,4,5)P3, GTP S-stimulated total
[3H]InsPs were unchanged, as expected. Only a small
amount of [3H]Ins(1,4,5)P3 was detected in
the presence of 300 µM Ins(1,4,5)P3 and
GTP S, which was not observed with 300 µM
Ins(1,4,5)P3 alone. Experiments performed using
AlF4 in place of GTP S gave similar
results (data not shown).

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 4.
Lack of effect of 300 µM Ins(1,4,5)P3 on G
protein-stimulated [3H]InsP generation.
[3H]Inositol-labeled, permeabilized NCM were treated for
10 min with 10 mM LiCl, then intracellular medium
containing LiCl was renewed for a further 20-min period, in the absence
of stimulus (open bars), or with the addition of 10 µM GTP S (filled bars), or with the addition
of 300 µM Ins(1,4,5)P3 and 10 µM GTP S (striped bars), or with the
addition of 300 µM Ins(1,4,5)P3 alone
(hatched bars). A representative experiment of two performed
in triplicate is shown, and an experiment was also performed using
AlF4 in place of GTP S with
identical results. * indicates significant difference between GTP S
treatment and no additions, and indicates significant difference
between Ins(1,4,5)P3 addition and Ins(1,4,5)P3 + GTP S
treatment (p < 0.05).
|
|
To confirm that [3H]Ins(1,4,5)P3 could be
successfully protected by the addition of excess unlabeled
Ins(1,4,5)P3 in NCM, we added 10 nM
[3H]Ins(1,4,5)P3 to permeabilized NCM not
previously labeled with [3H]inositol, in the absence or
presence of 300 µM Ins(1,4,5)P3 together with
10 mM LiCl for 20 min. As shown in Fig.
5, 300 µM Ins(1,4,5)P3 protected
[3H]Ins(1,4,5)P3 from dephosphorylation to
[3H]Ins(1,4)P2.

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 5.
Protection of
[3H]Ins(1,4,5)P3 by 300 µM unlabeled Ins(1,4,5)P3.
Permeabilized, unlabeled NCM were incubated for 10 min with 10 mM LiCl, followed by addition of
[3H]Ins(1,4,5)P3 (10 nM) in the
absence or presence of 300 µM unlabeled
Ins(1,4,5)P3 for 20 min. The major inositol phosphates
recovered were [3H]Ins(1,4,5)P3 and
[3H]Ins(1,4)P2. Open bars indicate
addition of 10 nM
[3H]Ins(1,4,5)P3 alone, solid bars
indicate addition of 10 nM
[3H]Ins(1,4,5)P3 and 300 µM
unlabeled Ins(1,4,5)P3. * indicates significant difference
between treatments (p < 0.01). Results are derived
from two separate experiments performed in triplicate.
|
|
 |
DISCUSSION |
The present study challenges the assumption that InsP
responses in NCM depend on the primary generation of
Ins(1,4,5)P3, followed by its metabolism to generate a
range of other InsPs. We provide evidence for generation of
Ins(1,4,5)P3 in response to elevation of intracellular
Ca2+, as shown by the marked increase in
Ins(1,4,5)P3 observed during the response to elevated free
Ca2+ in permeabilized NCM and by the sensitivity of A23187
stimulation to the PtdIns(4,5)P2-binding aminoglycoside
neomycin in intact NCM. In contrast to Ca2+-activated
responses, 1-adrenergic receptor stimulation leads to
InsP generation which is relatively insensitive to neomycin, and direct
G protein stimulation by either GTP S or
AlF4 initiates InsP responses which
are largely independent of Ins(1,4,5)P3.
Early studies in non-cardiac cell types suggested that there is a
change in the preferred substrate for phospholipase C away from
PtdIns(4,5)P2 as agonist stimulation is maintained, such that Ins(1,4,5)P3 generation predominates only in the
initial phase of the response (5, 6). In NCM at both the 30-s and 20-min time points, the total [3H]InsP response to A23187
was inhibited by neomycin, indicating Ins(1,4,5)P3
generation. In contrast, the response to NE was insensitive to neomycin
at both time points. Thus, although time course data showed increased
[3H]Ins(1,4,5)P3 early in both the NE and
A23187 responses, only the A23187 response was neomycin-sensitive in
terms of total [3H]InsPs generated. This shows that a
finding of increased [3H]Ins(1,4,5)P3 cannot
be taken alone as evidence that it is the primary source of accumulated
[3H]InsPs, even at an early time point.
Similar insensitivity of NE responses to neomycin has been observed in
adult rat cardiomyocytes (38) as well as normoxic preparations of adult
rat heart tissue (29) but InsP responses under reperfusion conditions,
during which large increases in Ins(1,4,5)P3 are observed,
are effectively blocked by aminoglycosides (13, 14, 17). Increases in
levels of all InsP isomers are inhibited by aminoglycosides under
reperfusion conditions, not merely Ins(1,4,5)P3. Although
neomycin at high concentrations may well have cellular effects
unrelated to its PtdIns(4,5)P2-binding capability, the
differential sensitivity of the Ca2+ and NE responses
to neomycin argues against a nonspecific action in this case. Thus,
these data suggest that increased cytosolic Ca2+ is a
stimulus for Ins(1,4,5)P3 generation, whereas
1-adrenergic receptor stimulation of PLC triggers an
InsP response that is largely independent of PtdIns(4,5)P2 hydrolysis.
As there are several G protein-coupled receptor systems present in NCM
that could activate PLC, we chose to examine InsP responses to direct G
protein activation in permeabilized NCM to test whether the relative
incapacity of 1-adrenergic receptor stimulation to
induce sustained Ins(1,4,5)P3 generation extended to all G protein-mediated PLC activities in NCM. Neither short-term (1 min) nor
long-term (20 min) G protein stimulation was able to significantly
increase [3H]Ins(1,4,5)P3 content in
permeabilized NCM even though total [3H]InsPs were
increased at 20 min. However, this did not reflect a fundamental
inability of the permeabilized NCM preparation to hydrolyze
[3H]PtdIns(4,5)P2, as elevation of free
Ca2+ in the medium for either 1 or 20 min led to a dramatic
increase in the amount of [3H]Ins(1,4,5)P3
recovered. The steady increase of [3H]InsPs following G
protein activation contrasted with the response to elevated free
Ca2+, in which both
[3H]Ins(1,4,5)P3 and total
[3H]InsPs increased rapidly up to 1 min, but the response
was not sustained for 20 min.
The use of permeabilized NCM provided the opportunity to directly
measure the contribution of [3H]Ins(1,4,5)P3
generation to G protein-mediated [3H]InsP responses by
competing for its breakdown with a large molar excess of unlabeled
Ins(1,4,5)P3. The inability of 300 µM
Ins(1,4,5)P3 to reduce the levels of unstimulated and
GTP S-stimulated [3H]Ins(1,4)P2 and
[3H]Ins(4)P implies that
[3H]Ins(1,4,5)P3 is not the source of these
[3H]InsPs. As the major labeled inositol phosphate which
accumulates is [3H]Ins(4)P, which can only be produced by
dephosphorylation of [3H]Ins(1,4)P2, the most
likely progenitor of InsPs in NCM is Ins(1,4)P2 derived
from PLC hydrolysis of PtdIns(4)P, as suggested in adult rat heart
(29). Direct hydrolysis of PtdIns, which has been reported as an
alternative to PtdIns(4,5)P2 hydrolysis (4, 5, 33) would
lead to increases in the levels of Ins(1)P rather than Ins(4)P.
Increases in [3H]Ins(1)P or [3H]Ins(3)P
(which cannot be resolved by high performance liquid chromatography)
were only minor in comparison to increases in [3H]Ins(4)P
observed during the [3H]InsP responses in either intact
or permeabilized NCM described in the present study.
The InsP generation model suggested by these experiments allows for
production of sn-1,2-diacylglycerol without concomitant generation of Ins(1,4,5)P3 in response to G protein
PLC-mediated stimuli. Activation of conventional and novel PKC isoforms
in heart has been reported under a number of conditions, especially in
relation to hypertrophic growth (39-41). Suppression of
Ins(1,4,5)P3 generation under physiological conditions in
NCM, as previously suggested for adult rat heart (29), lends support to
the view that increases in Ins(1,4,5)P3 are deleterious to
the heart (18). Direct intracellular application of
Ins(1,4,5)P3 causes action potential degeneration (9, 10)
and Ins(1,4,5)P3 generation has been shown to be related to
the initiation of arrhythmias under ischemia and reperfusion conditions
(11-17). It is therefore possible that the abbreviated InsP pathway
present in cardiac myocytes protects the heart from
Ins(1,4,5)P3 generation and consequent arrhythmias,
presumably arising from enhanced Ca2+ release from the
cardiac sarcoplasmic reticulum. If this is the case, then it is
interesting that Ca2+ overload itself causes
Ins(1,4,5)P3 generation, potentially initiating a positive
feedback relationship between Ca2+ and
Ins(1,4,5)P3 which would further aggravate any
electrophysiological damage to the heart.
An alternative explanation for preferential Ins(1,4)P2
generation in the heart is that Ins(1,4)P2 itself has a
signaling function. While Ins(1,4)P2 is generally
considered to be an inactive metabolite of Ins(1,4,5)P3,
there have been a number of studies suggesting that it has a role in
cellular growth (42, 43) and other metabolic pathways (44, 45).
Clearly, further investigation would be required to establish any such
role in the heart.
The mechanisms underlying the different responses to NE and
Ca2+ remain to be determined. Whereas PLC- isoforms
respond to G protein activation (46), PLC- isoforms (particularly
PLC- 1) are likely mediators of Ca2+-activated InsP
responses in the absence of other upstream signaling molecules (46,
47). Surprisingly, PLC- has somewhat less specificity for
PtdIns(4,5)P2 relative to PtdIns(4)P than does PLC- when
studied in vitro using synthetic lipid micelles (2). It is,
however, possible that the substrate specificities of the different PLC
isoforms might be altered by particular features of the cardiac sarcolemma.
In summary, the present study demonstrates that generation of
Ins(1,4,5)P3 in NCM requires Ca2+-mediated
activation of PLC and that G protein activation of PLC causes an InsP
response which is largely independent of Ins(1,4,5)P3 generation. Further studies will be required to elucidate the molecular events responsible for the selection between
Ins(1,4)P2 and Ins(1,4,5)P3 generation in
NCM.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Baker Medical Research
Institute, P. O. Box 6492, St. Kilda Rd. Central, Melbourne 8008, Victoria, Australia. Tel.: 61-3-9522-4333; Fax: 61-3-9521-1362; E-mail:
liz.woodcock@baker.edu.au.
 |
ABBREVIATIONS |
The abbreviations used are:
Ins(1, 4,5)P3, D-myo-inositol
1,4,5-trisphosphate;
Ins(1, 4)P2,
D-myo-inositol 1,4-bisphosphate;
Ins(4)P, D-myo-inositol 4-monophosphate;
Ins(1)P, D-myo-inositol 1-monophosphate;
InsP, inositol
phosphate;
PtdIns(4, 5)P2, phosphatidylinositol
4,5-bisphosphate;
PtdIns(4)P, phosphatidylinositol 4-monophosphate;
PLC, phospholipase C;
PKC, protein kinase C;
NE, norepinephrine;
GTP S, guanosine 5'-3-O-(thio)triphosphate;
NCM, neonatal
rat cardiomyocytes.
 |
REFERENCES |
| 1.
|
Berridge, M. J.
(1993)
Nature
361,
315-325[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Ryu, S. H.,
Suh, P.-G.,
Cho, K. S.,
Lee, K.-Y.,
and Rhee, S. G.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
6649-6653[Abstract/Free Full Text]
|
| 3.
|
Rhee, S. G.,
and Choi, K. D.
(1992)
J. Biol. Chem.
267,
12393-12396[Free Full Text]
|
| 4.
|
Wilson, D. B.,
Bross, T. E.,
Hofmann, S. L.,
and Majerus, P. W.
(1984)
J. Biol. Chem.
259,
11718-11724[Abstract/Free Full Text]
|
| 5.
|
Imai, A.,
and Gershengorn, M. C.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
8540-8544[Abstract/Free Full Text]
|
| 6.
|
Griendling, K. K.,
Rittenhouse, S. E.,
Brock, T. A.,
Ekstein, L. S.,
Gimbrone, M. A., Jr.,
and Alexander, R. W.
(1986)
J. Biol. Chem.
261,
5901-5906[Abstract/Free Full Text]
|
| 7.
|
Kentish, J. C.,
Barsotti, R. J.,
Lea, T. J.,
Mullican, I. P.,
Patel, J. R.,
and Ferenczi, M. A.
(1990)
Am. J. Physiol.
258,
H610-H615[Abstract/Free Full Text]
|
| 8.
|
Zhu, Y.,
and Nosek, T. M.
(1991)
Pflügers Arch.
418,
1-6[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Felzen, B.,
Shilkrut, M.,
Less, H.,
Sarapov, I.,
Maor, G.,
Coleman, R.,
Robinson, R. B.,
Berke, G.,
and Binah, O.
(1998)
Circ. Res.
82,
438-450[Abstract/Free Full Text]
|
| 10.
|
Gilbert, J. C.,
Shirayama, T.,
and Pappano, A. J.
(1991)
Circ. Res.
69,
1632-1639[Abstract/Free Full Text]
|
| 11.
|
Woodcock, E. A.,
Lambert, K. A.,
and Du, X.-J.
(1996)
J. Mol. Cell. Cardiol.
28,
2129-2138[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Anderson, K. E.,
Dart, A. M.,
and Woodcock, E. A.
(1995)
Circ. Res.
76,
261-268[Abstract/Free Full Text]
|
| 13.
|
Du, X.-J.,
Anderson, K. E.,
Jacobsen, A. N.,
Woodcock, E. A.,
and Dart, A. M.
(1995)
Circulation
91,
2712-2716[Abstract/Free Full Text]
|
| 14.
|
Jacobsen, A. N.,
Du, X.-J.,
Lambert, K. A.,
Dart, A. M.,
and Woodcock, E. A.
(1996)
Circulation
93,
23-26[Abstract/Free Full Text]
|
| 15.
|
Jacobsen, A. N.,
Du, X.-J.,
Dart, A. M.,
and Woodcock, E. A.
(1997)
Am. J. Physiol.
273,
H1119-H1125[Abstract/Free Full Text]
|
| 16.
|
Woodcock, E. A.,
Reyes, N.,
Jacobsen, A. N.,
and Du, X.-J.
(1999)
Circulation
99,
823-828[Abstract/Free Full Text]
|
| 17.
|
Bian, J. S.,
Zhang, W. M.,
Xia, Q.,
and Wong, T. M.
(1998)
J. Mol. Cell. Cardiol.
30,
2103-2110[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Woodcock, E. A.,
Matkovich, S. J.,
and Binah, O.
(1998)
Cardiovasc. Res.
40,
251-256[Free Full Text]
|
| 19.
|
Wu, D.,
Katz, A.,
Lee, C.-H.,
and Simon, M. I.
(1992)
J. Biol. Chem.
267,
25798-25802[Abstract/Free Full Text]
|
| 20.
|
Smrcka, A. V.,
Hepler, J. R.,
Brown, K. O.,
and Sternweis, P. C.
(1991)
Science
251,
804-807[Abstract/Free Full Text]
|
| 21.
|
Jalil, T.,
Takeishi, Y.,
and Walsh, R. A.
(1999)
Cardiovasc. Res.
44,
5-9[Free Full Text]
|
| 22.
|
Schnabel, P.,
Gaes, H.,
Nohr, T.,
Camps, M.,
and Boehm, M.
(1996)
J. Mol. Cell. Cardiol.
28,
2419-2427[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Hansen, C. A.,
Schroering, A. G.,
and Robishaw, J. D.
(1995)
J. Mol. Cell. Cardiol.
27,
471-484[Medline]
[Order article via Infotrieve]
|
| 24.
|
Gabev, E.,
Kasianowicz, J.,
Abbott, T.,
and McLauchlin, S.
(1989)
Biochim. Biophys. Acta
979,
105-122[Medline]
[Order article via Infotrieve]
|
| 25.
|
Simpson, P.,
McGrath, A.,
and Savion, S.
(1982)
Circ. Res.
51,
787-801[Abstract/Free Full Text]
|
| 26.
|
York, J. D.,
Ponder, J. W.,
and Majerus, P. W.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
5149-5153[Abstract/Free Full Text]
|
| 27.
|
Shears, S. B.
(1989)
Biochem. J.
260,
313-324[Medline]
[Order article via Infotrieve]
|
| 28.
|
Woodcock, E. A.
(1997)
Mol. Cell. Biochem.
172,
121-127[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Woodcock, E. A.,
Suss, M. B.,
and Anderson, K. E.
(1995)
Circ. Res.
76,
252-260[Abstract/Free Full Text]
|
| 30.
|
Steinberg, S. F.,
Kaplan, L. M.,
Inouye, T.,
Zhang, J. F.,
and Robinson, R. B.
(1989)
J. Pharmacol. Exp. Ther.
250,
1141-1148[Abstract/Free Full Text]
|
| 31.
|
Woodcock, E. A.,
Tanner, J. K.,
Fullerton, M.,
and Kuraja, I. J.
(1992)
Biochem. J.
281,
683-688
|
| 32.
|
Inhorn, R. C.,
and Majerus, P. W.
(1988)
J. Biol. Chem.
263,
14559-14565[Abstract/Free Full Text]
|
| 33.
|
Biden, T. J.,
Prugue, M. L.,
and Davison, A. G. M.
(1992)
Biochem. J.
285,
541-549
|
| 34.
|
Philippe, M.
(1994)
Biochem. Biophys. Res. Commun.
205,
245-250[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Hepler, J. R.,
Kozasa, T.,
Smrcka, A. V.,
Simon, M. I.,
Rhee, S. G.,
Sternweis, P. C.,
and Gilman, A. G.
(1993)
J. Biol. Chem.
268,
14367-14375[Abstract/Free Full Text]
|
| 36.
|
Bigay, J.,
Deterre, P.,
Pfister, C.,
and Chabre, M.
(1987)
EMBO J.
6,
2907-2913[Medline]
[Order article via Infotrieve]
|
| 37.
|
Laxminarayan, K. M.,
Chan, B. K.,
Tetaz, T.,
Bird, P. I.,
and Mitchell, C. A.
(1994)
J. Biol. Chem.
269,
17305-17310[Abstract/Free Full Text]
|
| 38.
|
Woodcock, E. A.,
and Lambert, K. A.
(1997)
J. Mol. Cell. Cardiol.
29,
3275-3283[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Gu, X.,
and Bishop, S. P.
(1994)
Circ. Res.
75,
926-931[Abstract/Free Full Text]
|
| 40.
|
Wakasaki, H.,
Koya, D.,
Schoen, F.,
Jirousek, M. R.,
Ways, D. K.,
Hoit, B. D.,
Walsh, R. A.,
and King, G. L.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
9320-9325[Abstract/Free Full Text]
|
| 41.
|
Bowling, N.,
Walsh, R. A.,
Song, G.,
Estridge, T.,
Sandusky, G. E.,
Fouts, R. L.,
Mintze, K.,
Pickard, T.,
Roden, R.,
Bristow, M. R.,
Sabbah, H. N.,
Mizrahi, J. L.,
Gromo, G.,
King, G. L.,
and Vlahos, C. J.
(1999)
Circulation
99,
384-391[Abstract/Free Full Text]
|
| 42.
|
Sylvia, V.,
Curtain, G.,
Norman, J.,
Stec, J.,
and Busbee, D.
(1988)
Cell
54,
651-658[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
York, J. D.,
Samitz, J. E.,
and Majerus, P. W.
(1994)
J. Biol. Chem.
269,
19992-19999[Abstract/Free Full Text]
|
| 44.
|
López-Coronado, J. M.,
Bellés, J. M.,
Lesage, F.,
Serrano, R.,
and Rodríguez, P. L.
(1999)
J. Biol. Chem.
274,
16034-16039[Abstract/Free Full Text]
|
| 45.
|
Spiegelberg, B. D.,
Xiong, J.-P.,
Smith, J. J.,
Gu, R. F.,
and York, J. D.
(1999)
J. Biol. Chem.
274,
13619-13628[Abstract/Free Full Text]
|
| 46.
|
Rhee, S. G.,
and Bae, Y. S.
(1997)
J. Biol. Chem.
272,
15045-15048[Free Full Text]
|
| 47.
|
Allen, V.,
Swigart, P.,
Cheung, R.,
Cockcroft, S.,
and Katan, M.
(1997)
Biochem. J.
327,
545-552
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. N Petrashevskaya, I. Bodi, S. E Koch, S. A Akhter, and A. Schwartz
Effects of {alpha}1-adrenergic stimulation on normal and hypertrophied mouse hearts. Relation to caveolin-3 expression
Cardiovasc Res,
August 15, 2004;
63(3):
561 - 572.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Woodcock, B. H. Wang, J. F. Arthur, A. Lennard, S. J. Matkovich, X.-J. Du, J. H. Brown, and R. D. Hannan
Inositol Polyphosphate 1-Phosphatase Is a Novel Antihypertrophic Factor
J. Biol. Chem.,
June 14, 2002;
277(25):
22734 - 22742.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Arthur, S. J. Matkovich, C. J. Mitchell, T. J. Biden, and E. A. Woodcock
Evidence for Selective Coupling of alpha 1-Adrenergic Receptors to Phospholipase C-beta 1 in Rat Neonatal Cardiomyocytes
J. Biol. Chem.,
September 28, 2001;
276(40):
37341 - 37346.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|